A natural compound melatonin enhances the effects of Nimotuzumab via inhibiting EGFR in glioblastomaCANCER LETTERSIF10.12024-06-012OAAI
Proteomics identifies EGF-like domain multiple 7 as a potential therapeutic target for epidermal growth factor receptor-positive gliomaCANCER COMMUNICATIONSIF24.92020-09-048OAAI
Future Strategies on Glioma Research: From Big Data to the ClinicGENOMICS PROTEOMICS & BIOINFORMATICSIF7.92017-08-0710OAAI